Difference between revisions of "To do page"
Jump to navigation
Jump to search
m |
m |
||
| Line 5: | Line 5: | ||
*Update information for all medications in the [[Drug index]], e.g. package insert versions | *Update information for all medications in the [[Drug index]], e.g. package insert versions | ||
*Add additional information to [[Consult topics in hematology and oncology]] | *Add additional information to [[Consult topics in hematology and oncology]] | ||
| − | |||
*Add additional Factor VIII inhibitor regimens & references to [[Coagulopathies]] page: Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol. 2003 Apr;121(1):21-35. [http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.2003.04162.x/abstract link to original article] | *Add additional Factor VIII inhibitor regimens & references to [[Coagulopathies]] page: Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol. 2003 Apr;121(1):21-35. [http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.2003.04162.x/abstract link to original article] | ||
*Add RTOG 9910 to [[Prostate cancer]]: http://jco.ascopubs.org/content/early/2014/12/22/JCO.2014.58.0662.full | *Add RTOG 9910 to [[Prostate cancer]]: http://jco.ascopubs.org/content/early/2014/12/22/JCO.2014.58.0662.full | ||
*Add pre-chemotherapy hepatitis B flowchart | *Add pre-chemotherapy hepatitis B flowchart | ||
*Add choriocarcinoma regimens to [[Germ cell tumors]] https://www.ncbi.nlm.nih.gov/pubmed/19370618 | *Add choriocarcinoma regimens to [[Germ cell tumors]] https://www.ncbi.nlm.nih.gov/pubmed/19370618 | ||
| − | |||
| − | |||
*Add arms A & B regimens from Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R, Tausch C, Seo JH, Tsai YF, Ratnayake J, McNally V, Ross G, Cortés J. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA). Ann Oncol. 2013 Sep;24(9):2278-84. [http://annonc.oxfordjournals.org/content/24/9/2278.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/23704196 PubMed] to [[breast cancer]] | *Add arms A & B regimens from Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R, Tausch C, Seo JH, Tsai YF, Ratnayake J, McNally V, Ross G, Cortés J. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA). Ann Oncol. 2013 Sep;24(9):2278-84. [http://annonc.oxfordjournals.org/content/24/9/2278.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/23704196 PubMed] to [[breast cancer]] | ||
| − | |||
*Add PMID 24428673, PMID 15939712, PMID 16467197, bexarotene for T-cell lymphoma | *Add PMID 24428673, PMID 15939712, PMID 16467197, bexarotene for T-cell lymphoma | ||
| − | * | + | *Verify at least one protocol for all RCT-based regimens |
| − | * | + | *Add ORR to all non-randomized regimens |
*Change "ICD-9 codes" to "ICD codes" and include ICD-10 codes | *Change "ICD-9 codes" to "ICD codes" and include ICD-10 codes | ||
*Use [https://addons.mozilla.org/en-US/firefox/addon/pinger/ Pinger] or [https://www.mediawiki.org/wiki/Extension:ExternalLinks ExternalLinks extension] to check for broken links on pages | *Use [https://addons.mozilla.org/en-US/firefox/addon/pinger/ Pinger] or [https://www.mediawiki.org/wiki/Extension:ExternalLinks ExternalLinks extension] to check for broken links on pages | ||
| Line 26: | Line 22: | ||
*Update [[Vesicant & irritant chemotherapy]] page | *Update [[Vesicant & irritant chemotherapy]] page | ||
*Add HLH-2004 to [[Hemophagocytic lymphohistiocytosis (HLH)]] https://www.ncbi.nlm.nih.gov/pubmed/16937360 | *Add HLH-2004 to [[Hemophagocytic lymphohistiocytosis (HLH)]] https://www.ncbi.nlm.nih.gov/pubmed/16937360 | ||
| + | *Update [[Antiemesis]] page | ||
| + | *Create a consistent level of evidence header for all non-randomized trials | ||
| + | *Change efficacy to follow the guidelines from [http://www.sciencedirect.com.proxy.library.vanderbilt.edu/science/article/pii/S0140673609604992|"Translating statistical findings into plain English"]. | ||
| + | *Disambiguate and link together induction and maintenance/consolidation for [[Chronic_lymphocytic_leukemia_(CLL)_and_Small_lymphocytic_lymphoma_(SLL)]], [[Diffuse_large_B-cell_lymphoma]], [[Mantle_cell_lymphoma]], and [[Multiple_myeloma]] | ||
| + | *Add LUX-Lung 3 and LUX-Lung 6 information to [[Non-small cell lung cancer]] http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2814%2971173-8/abstract | ||
Revision as of 02:18, 10 September 2017
This page is a running list of tasks that should be done for HemOnc.org. Contributors can either add additional items to be done here, or come here to look for ways to contribute to the site. Please move things from the "to be done" to the "completed" section once it's been done.
To be done
- Add more Example chemotherapy order sets for all regimens
- Update information for all medications in the Drug index, e.g. package insert versions
- Add additional information to Consult topics in hematology and oncology
- Add additional Factor VIII inhibitor regimens & references to Coagulopathies page: Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol. 2003 Apr;121(1):21-35. link to original article
- Add RTOG 9910 to Prostate cancer: http://jco.ascopubs.org/content/early/2014/12/22/JCO.2014.58.0662.full
- Add pre-chemotherapy hepatitis B flowchart
- Add choriocarcinoma regimens to Germ cell tumors https://www.ncbi.nlm.nih.gov/pubmed/19370618
- Add arms A & B regimens from Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R, Tausch C, Seo JH, Tsai YF, Ratnayake J, McNally V, Ross G, Cortés J. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA). Ann Oncol. 2013 Sep;24(9):2278-84. link to original article PubMed to breast cancer
- Add PMID 24428673, PMID 15939712, PMID 16467197, bexarotene for T-cell lymphoma
- Verify at least one protocol for all RCT-based regimens
- Add ORR to all non-randomized regimens
- Change "ICD-9 codes" to "ICD codes" and include ICD-10 codes
- Use Pinger or ExternalLinks extension to check for broken links on pages
Completed
- Disambiguate and link together induction and maintenance/consolidation for Follicular_lymphoma
- Alphabetize and verify regimens & references on Breast cancer page
- Link all randomized trials together
- Update Vesicant & irritant chemotherapy page
- Add HLH-2004 to Hemophagocytic lymphohistiocytosis (HLH) https://www.ncbi.nlm.nih.gov/pubmed/16937360
- Update Antiemesis page
- Create a consistent level of evidence header for all non-randomized trials
- Change efficacy to follow the guidelines from "Translating statistical findings into plain English".
- Disambiguate and link together induction and maintenance/consolidation for Chronic_lymphocytic_leukemia_(CLL)_and_Small_lymphocytic_lymphoma_(SLL), Diffuse_large_B-cell_lymphoma, Mantle_cell_lymphoma, and Multiple_myeloma
- Add LUX-Lung 3 and LUX-Lung 6 information to Non-small cell lung cancer http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2814%2971173-8/abstract